Merck's WELIREG Launch Marks a Milestone in PCPG Treatment Advancements Merck introduces WELIREG, the first oral therapy for pheochromocytoma and paraganglioma, reshaping advanced neuroendocrine tumor treatment.

Merck's WELIREG Launch Marks a Milestone in PCPG Treatment Advancements #USA #Las_Vegas #Merck #WELIREG #PCPG